MIND MEDICINE MINDMED INC. [MMEDF: OTCQB]

3.50 -0.14 (-3.85%) 03/02/2021 Delayed 15 minutes

Open	$3.68	Daily Range	$3.495-$3.70
Prev. Close	$3.64	52 Week Range	$0.0833-$5.07
Volume	1,515,782

Quote Data Realtime

Inside Quote
Bid	Ask	Last Inside Change
$3.49 x 7115 shares	$3.50 x 14313 shares	03/02 5:00 PM EST

Level II Quote Montage

BID

ASK

MMID	Bid Price	Bid Size	Date/Time
OTCX	3.49	6002	15:59
ETRF	3.49	400	15:59
CDEL	3.49	263	15:59
NITE	3.49	250	15:59
INTL	3.49	200	15:59
VALX	3.48	5600	15:59
JANE	3.48	5000	15:59
GTSM	3.45	847	15:59
CSTI	3.45	100	15:56
VNDM	2.99	6000	11:27
PAUL	2.88	100	02/23
MAXM	2.71	8900	09:30
LAFC	2.52	100	12/22
CANT	2.52	100	02/23
VERT	1.97	100	01/28
MCAP	1.71	100	15:59
PUMA	1.42	100	08:10
WABR	1.00	100	02/01
cBGCE	1.00	100	02/23

MMID	Ask Price	Ask Size	Date/Time
CDEL	3.50	11877	15:59
NITE	3.50	2436	15:59
OTCX	3.52	13000	15:59
INTL	3.52	2900	15:59
VALX	3.53	11200	15:59
JANE	3.53	5000	15:59
ETRF	3.53	100	15:59
CSTI	3.58	1000	15:59
GTSM	3.69	1200	15:26
MAXM	4.00	100	07:35
PAUL	4.50	100	02/17
VERT	5.00	100	01/22
MCAP	5.31	100	15:59
PUMA	5.44	100	08:10
LAFC	5.45	100	12/14
CANT	6.00	100	01/21
VNDM	7.04	100	14:38
WABR	100.00	100	02/12
cBGCE	5.98	100	02/23

The quotes displayed here are published by market makers on the OTC Markets Group Inc. electronic inter-dealer quotation and trading system for OTC securities. Please see Terms of Service and Risk Warning for more information.

MMID - Market maker quotation published in OTC Link that meets the Inside market | MMID - Market maker quotation published in OTC Link | cMMID - Closed quote | Unpriced - Unpriced quote in OTC Link | MMIDu - Unsolicited market maker quotation published in OTC Link

The Globe and Mail

Former cannabis executives betting psychedelic drugs could be the next big thing

“There’s a lot of untapped value in psychedelic substances because they’re [illegal],” said JR Rahn, founder of Toronto-based MindMed, which counts Canopy founder Bruce Linton and Shark Tank star Kevin O’Leary among its early investors.

Download PDF

Former cannabis executives betting psychedelic drugs could be the next big thing

Former cannabis executives betting psychedelic drugs could be the next big thing

Browse more articles